Skip to main content
Clinical Trials/JPRN-UMIN000024665
JPRN-UMIN000024665Not yet recruiting未知

Assessment of nocturnal scratching activity in atopic dermatitis patients with scratching-detecting device

estle Skin Health S.A.0 sites35 target enrollmentStarted: November 18, 2016Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor
Enrollment
35

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • 1) The subject with a diagnosis of atopic dermatitis based on 'Definition and diagnostic criteria for atopic dermatitis' by the Japanese Dermatological Association
  • 2) The subject aged >= 20 years at the time of informed consent.
  • 3) The moderate to severe atopic dermatitis patients with > score 7 in Eczema Area and Severity Index (EASI).
  • 4) The subject with mean itch score >= 5 in Numerical Rating Scale (NRS) during 7 days before the measurement. Itch intensity is self-measured on a 10-pt numerical scale, where 0 = no itch and 10 = worst possible itch.
  • 5) The subject with itch score >= 5 in NRS on the measurement day.
  • 6) The subject without change in treatment including atopic dermatitis during 7 days before the measurement.
  • 7) The subject usually takes >= 4 hours of nocturnal sleep.
  • 8) The subject gives informed consent in writing for the participation in this study including video shooting of nocturnal sleep.
  • Atopic dermatitis patients
  • 1) The subject with a diagnosis of atopic dermatitis based on 'Definition and diagnostic criteria for atopic dermatitis' by the Japanese Dermatological Association.
  • 2) The subject aged >= 20 years at the time of informed consent.
  • 3) The subject without change in treatment including atopic dermatitis during 7 days before the measurement.
  • 4) The subject gives informed consent in writing for the participation in this study.
  • Healthy Adults
  • 1) The subject aged >= 20 years at the time of informed consent.
  • 2) The subject who is assessed as healthy by the principal investigator or subinvestigators.
  • 3) The subject with mean itch score 0 in NRS during 7 days before the measurement. Short-time mild itch induced by external stimulus is not assessed as significant.
  • 4) The subject with itch score 0 in NRS on the measurement day. Short-time mild itch induced by external stimulus is not assessed as significant.
  • 5) The subject gives informed consent in writing for the participation in this study.

Exclusion Criteria

  • 1) The subject has difficulty in making a decision by dementia or something.
  • 2) The subject has a past medical history of disturbance of consciousness.
  • 3) The subject is addicted to drug or alcohol.
  • 4) The subject takes psychoactive drugs or meets indication for treatment of those drugs.
  • 5) The subject has a serious complication of hepatic, renal, cardiac, hematological, endocrine, metabolic, pulmonary, or gastrointestinal disease.
  • 6) Others who are assessed ineligible for this study by the principal investigator or subinvestigators.
  • 1) The subject has difficulty in making a decision by dementia or something.
  • 2) The subject has a past medical history of disturbance of consciousness.
  • 3) The subject is addicted to drug or alcohol.
  • 4) The subject takes psychoactive drugs or meets indication for treatment of those drugs.
  • 5) The subject has a serious complication of hepatic, renal, cardiac, hematological, endocrine, metabolic, pulmonary, or gastrointestinal disease.
  • 6) Others who are assessed ineligible for this study by the principal investigator or subinvestigators.

Investigators

Sponsor
estle Skin Health S.A.

Similar Trials